SEARCH:   Advanced

Blood, 1 September 2005, Vol. 106, No. 5, pp. 1590-1600. Prepublished online as a Blood First Edition Paper on May 24, 2005; DOI 10.1182/blood-2005-03-0860. This Article Full Text Full Text (PDF) Supplemental Table All Versions of this Article: 2005-03-0860v1 106/5/1590    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Iwasaki, H. Articles by Akashi, K. Search for Related Content PubMed PubMed Citation Articles by Iwasaki, H. Articles by Akashi, K. Related Collections Hematopoiesis and Stem Cells Gene Expression Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  HEMATOPOIESIS Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation Hiromi Iwasaki, Chamorro Somoza, Hirokazu Shigematsu, Estelle A. Duprez, Junko Iwasaki-Arai, Shin-ichi Mizuno, Yojiro Arinobu, Kristin Geary, Pu Zhang, Tajhal Dayaram, Maris L. Fenyus, Shannon Elf, Susan Chan, Philippe Kastner, Claudia S. Huettner, Richard Murray, Daniel G. Tenen, and Koichi Akashi From the Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; the Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan; Arbor Vitae, Sunnyvale, CA; Harvard Institutes of Medicine, Harvard Medical School, Boston, MA; the Institut de Genetique et de Biologie Moleculaire et Cellulaire, CEDEX, France; and EOS Biotech, South San Francisco, CA. The PU.1 transcription factor is a key regulator of hematopoietic development, but its role at each hematopoietic stage remains unclear. In particular, the expression of PU.1 in hematopoietic stem cells (HSCs) could simply represent "priming" of genes related to downstream myelolymphoid lineages. By using a conditional PU.1 knock-out model, we here show that HSCs express PU.1, and its constitutive expression is necessary for maintenance of the HSC pool in the bone marrow. Bone marrow HSCs disrupted with PU.1 in situ could not maintain hematopoiesis and were outcompeted by normal HSCs. PU.1-deficient HSCs also failed to generate the earliest myeloid and lymphoid progenitors. PU.1 disruption in granulocyte/monocyte-committed progenitors blocked their maturation but not proliferation, resulting in myeloblast colony formation. PU.1 disruption in common lymphoid progenitors, however, did not prevent their B-cell maturation. In vivo disruption of PU.1 in mature B cells by the CD19-Cre locus did not affect B-cell maturation, and PU.1-deficient mature B cells displayed normal proliferation in response to mitogenic signals including the cross-linking of surface immunoglobulin M (IgM). Thus, PU.1 plays indispensable and distinct roles in hematopoietic development through supporting HSC self-renewal as well as commitment and maturation of myeloid and lymphoid lineages. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: A. Schuler, M. Schwieger, A. Engelmann, K. Weber, S. Horn, U. Muller, M. A. Arnold, E. N. Olson, and C. Stocking The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate Blood, May 1, 2008; 111(9): 4532 - 4541. [Abstract] [Full Text] [PDF] L. Gutierrez, S. Tsukamoto, M. Suzuki, H. Yamamoto-Mukai, M. Yamamoto, S. Philipsen, and K. Ohneda Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis Blood, April 15, 2008; 111(8): 4375 - 4385. [Abstract] [Full Text] [PDF] R. Monni, L. Haddaoui, A. Naba, I. Gallais, M. Arpin, P. Mayeux, and F. Moreau-Gachelin Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia Blood, March 15, 2008; 111(6): 3163 - 3172. [Abstract] [Full Text] [PDF] V. Olive, N. Wagner, S. Chan, P. Kastner, C. Vannetti, F. Cuzin, and M. Rassoulzadegan PU.1 (Sfpi1), a pleiotropic regulator expressed from the first embryonic stages with a crucial function in germinal progenitors Development, November 1, 2007; 134(21): 3815 - 3825. [Abstract] [Full Text] [PDF] C. Yeamans, D. Wang, I. Paz-Priel, B. E. Torbett, D. G. Tenen, and A. D. Friedman C/EBP{alpha} binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment Blood, November 1, 2007; 110(9): 3136 - 3142. [Abstract] [Full Text] [PDF] A. Uhmann, K. Dittmann, F. Nitzki, R. Dressel, M. Koleva, A. Frommhold, A. Zibat, C. Binder, I. Adham, M. Nitsche, et al. The Hedgehog receptor Patched controls lymphoid lineage commitment Blood, September 15, 2007; 110(6): 1814 - 1823. [Abstract] [Full Text] [PDF] H. Tatetsu, S. Ueno, H. Hata, Y. Yamada, M. Takeya, H. Mitsuya, D. G. Tenen, and Y. Okuno Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth Cancer Res., June 1, 2007; 67(11): 5328 - 5336. [Abstract] [Full Text] [PDF] R. Hu, S. M. Sharma, A. Bronisz, R. Srinivasan, U. Sankar, and M. C. Ostrowski Eos, MITF, and PU.1 Recruit Corepressors to Osteoclast-Specific Genes in Committed Myeloid Progenitors Mol. Cell. Biol., June 1, 2007; 27(11): 4018 - 4027. [Abstract] [Full Text] [PDF] T. Maeda, T. Merghoub, R. M. Hobbs, L. Dong, M. Maeda, J. Zakrzewski, M. R.M. van den Brink, A. Zelent, H. Shigematsu, K. Akashi, et al. Regulation of B Versus T Lymphoid Lineage Fate Decision by the Proto-Oncogene LRF Science, May 11, 2007; 316(5826): 860 - 866. [Abstract] [Full Text] [PDF] R. P. DeKoter, B. L. Schweitzer, M. B. Kamath, D. Jones, H. Tagoh, C. Bonifer, D. A. Hildeman, and K. J. Huang Regulation of the Interleukin-7 Receptor {alpha} Promoter by the Ets Transcription Factors PU.1 and GA-binding Protein in Developing B Cells J. Biol. Chem., May 11, 2007; 282(19): 14194 - 14204. [Abstract] [Full Text] [PDF] B. Grondin, M. Lefrancois, M. Tremblay, M. Saint-Denis, A. Haman, K. Waga, A. Bedard, D. G. Tenen, and T. Hoang c-Jun Homodimers Can Function as a Context-Specific Coactivator Mol. Cell. Biol., April 15, 2007; 27(8): 2919 - 2933. [Abstract] [Full Text] [PDF] P. Rimmele, O. Kosmider, P. Mayeux, F. Moreau-Gachelin, and C. Guillouf Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation Blood, April 1, 2007; 109(7): 3007 - 3014. [Abstract] [Full Text] [PDF] K. Uchida, D. C. Beck, T. Yamamoto, P.-Y. Berclaz, S. Abe, M. K. Staudt, B. C. Carey, M.-D. Filippi, S. E. Wert, L. A. Denson, et al. GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis N. Engl. J. Med., February 8, 2007; 356(6): 567 - 579. [Abstract] [Full Text] [PDF] L. Talebian, Z. Li, Y. Guo, J. Gaudet, M. E. Speck, D. Sugiyama, P. Kaur, W. S. Pear, I. Maillard, and N. A. Speck T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBF{beta} dosage. Blood, January 1, 2007; 109(1): 11 - 21. [Abstract] [Full Text] [PDF] W.-C. Chou, D. E. Levy, and C.-K. Lee STAT3 positively regulates an early step in B-cell development Blood, November 1, 2006; 108(9): 3005 - 3011. [Abstract] [Full Text] [PDF] B. L. Schweitzer, K. J. Huang, M. B. Kamath, A. V. Emelyanov, B. K. Birshtein, and R. P. DeKoter Spi-C Has Opposing Effects to PU.1 on Gene Expression in Progenitor B Cells J. Immunol., August 15, 2006; 177(4): 2195 - 2207. [Abstract] [Full Text] [PDF] C. B. Franco, D. D. Scripture-Adams, I. Proekt, T. Taghon, A. H. Weiss, M. A. Yui, S. L. Adams, R. A. Diamond, and E. V. Rothenberg Notch/Delta signaling constrains reengineering of pro-T cells by PU.1 PNAS, August 8, 2006; 103(32): 11993 - 11998. [Abstract] [Full Text] [PDF] T. Katsumoto, Y. Aikawa, A. Iwama, S. Ueda, H. Ichikawa, T. Ochiya, and I. Kitabayashi MOZ is essential for maintenance of hematopoietic stem cells. Genes & Dev., May 15, 2006; 20(10): 1321 - 1330. [Abstract] [Full Text] [PDF] K. Wagner, P. Zhang, F. Rosenbauer, B. Drescher, S. Kobayashi, H. S. Radomska, J. L. Kutok, D. G. Gilliland, J. Krauter, and D. G. Tenen Absence of the transcription factor CCAAT enhancer binding protein {alpha} results in loss of myeloid identity in bcr/abl-induced malignancy PNAS, April 18, 2006; 103(16): 6338 - 6343. [Abstract] [Full Text] [PDF] M. D. Liang, Y. Zhang, D. McDevit, S. Marecki, and B. S. Nikolajczyk The Interleukin-1beta Gene Is Transcribed from a Poised Promoter Architecture in Monocytes J. Biol. Chem., April 7, 2006; 281(14): 9227 - 9237. [Abstract] [Full Text] [PDF] G. V. Priestley, L. M. Scott, T. Ulyanova, and T. Papayannopoulou Lack of {alpha}4 integrin expression in stem cells restricts competitive function and self-renewal activity Blood, April 1, 2006; 107(7): 2959 - 2967. [Abstract] [Full Text] [PDF] D. Metcalf, A. Dakic, S. Mifsud, L. Di Rago, L. Wu, and S. Nutt Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia PNAS, January 31, 2006; 103(5): 1486 - 1491. [Abstract] [Full Text] [PDF] M. Ye, O. Ermakova, and T. Graf PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch J. Exp. Med., November 21, 2005; 202(10): 1411 - 1422. [Abstract] [Full Text] [PDF]

	Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020